Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
139,4 USD | +0,24% | +0,60% | +5,83% |
Omzet 2024 * | 2,21 mld. 2,04 mld. | Omzet 2025 * | 2,52 mld. 2,32 mld. | Marktkapitalisatie | 13,88 mld. 12,77 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 492 mln. 453 mln. | Nettowinst (verlies) 2025 * | 652 mln. 600 mln. | EV/omzet 2024 * | 5,24 x |
Nettoliquiditeiten 2024 * | 2,28 mld. 2,1 mld. | Nettoliquiditeiten 2025 * | 3,03 mld. 2,79 mld. | EV/omzet 2025 * | 4,31 x |
K/w-verhouding 2024 * |
29,7
x | K/w-verhouding 2025 * |
22,3
x | Werknemers | 1.400 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,54% |
Recentste transcriptie over Neurocrine Biosciences, Inc.
1 dag | +0,24% | ||
1 week | +0,60% | ||
Lopende maand | +6,93% | ||
1 maand | +5,39% | ||
3 maanden | +16,28% | ||
6 maanden | +24,53% | ||
Lopend jaar | +5,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Director of Finance/CFO | 44 | 01-11-17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01-04-99 |
George Morrow
BRD | Director/Board Member | 72 | 01-10-15 |
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
13.65% | 227 M€ | +9,20% | - | |
3.81% | 1 M€ | -.--% | - | |
1.85% | 8 M€ | +5,61% | ||
1.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-03-24 | 139,4 | +0,24% | 664 683 |
15-03-24 | 139,1 | -0,04% | 1 739 211 |
14-03-24 | 139,2 | -1,86% | 1 182 246 |
13-03-24 | 141,8 | +2,95% | 1 073 582 |
12-03-24 | 137,7 | -0,63% | 650 983 |
uitgestelde koers Nasdaq, 18 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,83% | 13,88 mld. | |
+1,10% | 106 mld. | |
+9,29% | 103 mld. | |
-3,00% | 21,44 mld. | |
-11,89% | 22,11 mld. | |
-26,59% | 20,99 mld. | |
-5,20% | 19,44 mld. | |
-6,58% | 17,6 mld. | |
+7,46% | 11,75 mld. | |
+28,56% | 11,64 mld. |